Publication | Closed Access

AMPA receptor antagonists, GYKI 52466 and NBQX, do not block the induction of long-term potentiation at therapeutically relevant concentrations

Functional SelectivityMedicinePhysiologyGyki 52466Receptor (Biochemistry)Pharmacological AgentNeuropharmacologyAmpa Receptor AntagonistsLong-term PotentiationPharmacotherapyNeuroscienceExperimental PharmacologyMechanism Of ActionPharmacology